Pulmonary vascular disease (PVD) in patients with Sjögren syndrome - a prospective cross-sectional study P. Douschan (Graz, Austria), J. Horwath-Winter (Graz, Austria), J. Hermann (Graz, Austria), M. Stradner (Graz, Austria), T. Sassmann (Graz, Austria), V. Foris (Graz, Austria), A. Avian (Graz, Austria), H. Olschewski (Graz, Austria), G. Kovacs (Graz, Austria)
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Disease area: Pulmonary vascular diseasesRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Douschan (Graz, Austria), J. Horwath-Winter (Graz, Austria), J. Hermann (Graz, Austria), M. Stradner (Graz, Austria), T. Sassmann (Graz, Austria), V. Foris (Graz, Austria), A. Avian (Graz, Austria), H. Olschewski (Graz, Austria), G. Kovacs (Graz, Austria). Pulmonary vascular disease (PVD) in patients with Sjögren syndrome - a prospective cross-sectional study. 5455
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Pulmonary arterial hypertension associated with primary Sjögren's syndrome: a multicentre cohort study from China Source: Eur Respir J, 56 (5) 1902157; 10.1183/13993003.02157-2019 Year: 2020
Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976–2013 Source: Eur Respir J , 49 (2) 1601290; DOI: 10.1183/13993003.01290-2016 Year: 2017
Pulmonary arterial hypertension related with congenital heart disease (PAH r-CHD): a retrospective study of 21 patients Source: Annual Congress 2009 - Pulmonary circulation Year: 2009
Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study Source: Eur Respir J, 53 (2) 1801186; 10.1183/13993003.01186-2018 Year: 2019
Prevalence and mechanism of pulmonary hypertension in sickle cell disease: a prospective multicentre french study Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009
Observational retrospective study on the treatment of pulmonary hypertension (PH) associated to pulmonary disease in patient with PH out of proportion Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013
PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016
Prevalence of cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018
Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study Source: Eur Respir J, 54 (4) 1900897; 10.1183/13993003.00897-2019 Year: 2019
Acute coronary syndrome and OSAHS an unequivocal association (prospective study) Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
Clinical features in patients diagnosed of pulmonary hypertension: a retrospective study of 15 cases Source: Eur Respir J 2005; 26: Suppl. 49, 520s Year: 2005
Idiopathic pulmonary fibrosis (IPF) patients in Poland – preliminary cohort analysis of EMPIRE registry Source: International Congress 2017 – ILDs: clinical aspects Year: 2017
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report Source: International Congress 2015 – IPF: clinical aspects Year: 2015
Multi-institutional prospective registry in pulmonary hypertension associated with respiratory disease in Japan. Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018
Economic evaluation of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: A retrospective, case-controlled, cost of illness study Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010
LATE-BREAKING ABSTRACT: COPD-associated severe pulmonary hypertension (COPDPH): results of a 16-weeks prospective multicenter, double-blind, placebo-controlled randomized clinical trial (RCT) [SPHERIC-1 (http://clinicaltrials.gov/ct2/show/NCT01441934)] investigating the effect of sildenafil citrate (Sld) on pulmonary vascular resistance (PVR) and PaO2. Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013
Association between chronic obstructive pulmonary disease and endometriosis: a population-based cohort study Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases Year: 2020
Late Breaking Abstract - COVID-19 in patients with pulmonary hypertension: a national prospective cohort study Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021
Phenotype of patients with severe pulmonary hypertension secondary to chronic obstructive pulmonary disease: A multicentre study. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020
Diaphragm ultrasound in patients with interstitial lung disease (ILD): a prospective study. Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021